Clinical Trial Update: Filling Bone Defects/Voids With Autologous BonoFill For Maxillofacial Bone Regeneration [Phase 1, Phase 2]

View source ↗

Summary

The entry notes completion of Phase 1/Phase 2 trials evaluating autologous BonoFill for filling bone voids in the maxillofacial region.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Maxillofacial Bone Defects

Drugs mentioned

• BonoFill (Autologous bone graft substitute)

Snippet

Sponsor: BonusBio Group Ltd | Conditions: Bone Void in the Maxillofacial Area | Phase 1, Phase 2 | Status: COMPLETED